198 related articles for article (PubMed ID: 31334442)
21. Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults.
Flores YN; Velázquez-Cruz R; Ramírez P; Bañuelos M; Zhang ZF; Yee HF; Chang SC; Canizales-Quinteros S; Quiterio M; Cabrera-Alvarez G; Patiño N; Salmerón J
Mol Biol Rep; 2016 Dec; 43(12):1359-1369. PubMed ID: 27752939
[TBL] [Abstract][Full Text] [Related]
22. Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population.
Wang X; Liu Z; Wang K; Wang Z; Sun X; Zhong L; Deng G; Song G; Sun B; Peng Z; Liu W
Front Genet; 2016; 7():140. PubMed ID: 27532011
[TBL] [Abstract][Full Text] [Related]
23. I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease.
Park JH; Cho B; Kwon H; Prilutsky D; Yun JM; Choi HC; Hwang KB; Lee IH; Kim JI; Kong SW
Liver Int; 2015 Dec; 35(12):2537-46. PubMed ID: 26148225
[TBL] [Abstract][Full Text] [Related]
24. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
Nakamura M; Kanda T; Nakamoto S; Miyamura T; Jiang X; Wu S; Yokosuka O
PLoS One; 2013; 8(12):e81312. PubMed ID: 24349054
[TBL] [Abstract][Full Text] [Related]
25. Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China.
Liao S; An K; Liu Z; He H; An Z; Su Q; Li S
J Clin Lab Anal; 2022 Sep; 36(9):e24626. PubMed ID: 35881683
[TBL] [Abstract][Full Text] [Related]
26. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
Valenti L; Alisi A; Galmozzi E; Bartuli A; Del Menico B; Alterio A; Dongiovanni P; Fargion S; Nobili V
Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
[TBL] [Abstract][Full Text] [Related]
27. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
Zhang RN; Zheng RD; Mi YQ; Zhou D; Shen F; Chen GY; Zhu CY; Pan Q; Fan JG
Dig Dis Sci; 2016 Aug; 61(8):2284-2293. PubMed ID: 27059980
[TBL] [Abstract][Full Text] [Related]
28. Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population.
Narayanasamy K; Karthick R; Panneerselvam P; Mohan N; Ramachandran A; Prakash R; Rajaram M
J Gene Med; 2020 Apr; 22(4):e3160. PubMed ID: 31945251
[TBL] [Abstract][Full Text] [Related]
29. [Correlation between PNPLA3 rs738409 and TM6SF2 rs58542926 gene polymorphism and primary liver cancer in the Han Population of China's Northeast region].
Bing H; Wang W; Li YL
Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):156-162. PubMed ID: 33685085
[No Abstract] [Full Text] [Related]
30.
Li G; Tang LJ; Zhu PW; Huang OY; Rios RS; Zheng KI; Chen SD; Ma HL; Targher G; Byrne CD; Pan XY; Zheng MH
J Clin Transl Hepatol; 2022 Jun; 10(3):439-448. PubMed ID: 35836754
[TBL] [Abstract][Full Text] [Related]
31. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
[TBL] [Abstract][Full Text] [Related]
32. PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease.
Wang JZ; Cao HX; Chen JN; Pan Q
World J Clin Cases; 2018 Aug; 6(8):167-175. PubMed ID: 30148144
[TBL] [Abstract][Full Text] [Related]
33. Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study.
Kanth VV; Sasikala M; Rao PN; Steffie Avanthi U; Rao KR; Nageshwar Reddy D
World J Hepatol; 2014 Jun; 6(6):435-42. PubMed ID: 25018854
[TBL] [Abstract][Full Text] [Related]
34. Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients.
Gavril OI; Arhire LI; Gavril RS; Zota MI; Gherasim A; Nita O; Drugescu A; Oprescu AC; Esanu IM; Mitu F; Graur M; Mihalache L
Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833467
[No Abstract] [Full Text] [Related]
35. GWAS-Identified Common Variants With Nonalcoholic Fatty Liver Disease in Chinese Children.
Shang XR; Song JY; Liu FH; Ma J; Wang HJ
J Pediatr Gastroenterol Nutr; 2015 May; 60(5):669-74. PubMed ID: 25522307
[TBL] [Abstract][Full Text] [Related]
36. The PNPLA3 rs738409 Variant but not MBOAT7 rs641738 is a Risk Factor for Nonalcoholic Fatty Liver Disease in Obese U.S. Children of Hispanic Ethnicity.
Mansoor S; Maheshwari A; Di Guglielmo M; Furuya K; Wang M; Crowgey E; Molle-Rios Z; He Z
Pediatr Gastroenterol Hepatol Nutr; 2021 Sep; 24(5):455-469. PubMed ID: 34557398
[TBL] [Abstract][Full Text] [Related]
37. Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children.
Lee KJ; Moon JS; Kim NY; Ko JS
Pediatr Obes; 2022 Feb; 17(2):e12852. PubMed ID: 34490745
[TBL] [Abstract][Full Text] [Related]
38. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
Rotman Y; Koh C; Zmuda JM; Kleiner DE; Liang TJ;
Hepatology; 2010 Sep; 52(3):894-903. PubMed ID: 20684021
[TBL] [Abstract][Full Text] [Related]
39. Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.
Guichelaar MM; Gawrieh S; Olivier M; Viker K; Krishnan A; Sanderson S; Malinchoc M; Watt KD; Swain JM; Sarr M; Charlton MR
Obesity (Silver Spring); 2013 Sep; 21(9):1935-41. PubMed ID: 23418085
[TBL] [Abstract][Full Text] [Related]
40. Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients.
Enomoto H; Aizawa N; Hasegawa K; Ikeda N; Sakai Y; Yoh K; Takata R; Yuri Y; Kishino K; Shimono Y; Ishii N; Takashima T; Nishimura T; Nishikawa H; Iwata Y; Iijima H; Nishiguchi S
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
